Cardio Diagnostics Holdings (NASDAQ: CDIO) is taking its cardiovascular risk assessment tools directly to employers and benefits decision-makers at four national benefits conferences in June, aiming to address the substantial financial and health burden of heart disease. The company’s engagement comes as cardiovascular disease remains one of the costliest conditions for U.S. employers, driving higher medical expenses, lost productivity, and long-term care costs.
According to the American Heart Association, direct cardiovascular healthcare costs accounted for approximately 11% of all U.S. healthcare expenditures in 2020–2021, more than any other major diagnostic category. A single heart attack or major cardiovascular event can have cascading effects on employers, insurers, and healthcare systems. By identifying risk earlier, Cardio Diagnostics’ suite of solutions enables more targeted interventions and preventive care, potentially reducing the frequency and severity of such events.
The company’s participation in these conferences underscores a broader shift in employee benefits strategy—from reactive treatment to proactive risk management. Employers are increasingly seeking data-driven tools to manage population health and contain costs. Cardio Diagnostics’ offerings, which include genetic and epigenetic testing, provide insights into an individual’s risk profile, allowing for personalized prevention plans.
“Cardiovascular disease is not only a leading cause of death but also a major driver of healthcare spending,” said a company representative. “By partnering with employers, we can help identify at-risk individuals before an event occurs, improving health outcomes and reducing financial strain on benefit plans.” The company’s solutions are designed to integrate seamlessly into existing wellness programs and benefits structures.
The conferences provide a platform for Cardio Diagnostics to showcase its technology and discuss the economic rationale for early detection. With healthcare costs continuing to rise, employers are under pressure to find effective strategies that deliver measurable returns. The company’s approach aligns with value-based care models that prioritize prevention and outcomes over volume of services.
For more information, visit the company’s newsroom at https://ibn.fm/CDIO. Details on the terms of use and disclaimers are available at http://IBN.fm/Disclaimer.
